Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer | Multispan, Inc

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer

GPCR Target: HEK293T-WT SMO membranes

Authors: Tomassi S, et al.

Journal: RSC Med Chem. 2024;16(1):77-97. doi:10.1039/d4md00553h

Year Published: 2024

Leave a Reply Cancel reply